文献速递角膜与眼表疾病

无缝合浅层前板层角膜移植术治疗重复准分子激光表面消融术后复发性角膜混浊

Sutureless superficial anterior lamellar keratoplasty for recurrent corneal haze after repeat excimer laser surface ablation.
PubMed 文献 · Br J Ophthalmol · 2019-07-05

一项在意大利Forlì三级转诊中心开展的前瞻性干预研究,纳入10只光屈光性角膜切削术后角膜混浊、经光治疗性角膜切削术(联合或不联合丝裂霉素C)后复发并接受无缝合浅层前板层角膜移植术(SALK)的眼。术后5年随访期间无混浊复发,最佳眼镜矫正视力(BSCVA)从术前平均0.46 logMAR(SD=0.12)改善至5年时0.12(SD=0.12,p=0.0001),但存在显著手术源性散光(SIA)。

要点

  • 无缝合SALK术后5年内无任何眼出现混浊复发。
  • BSCVA在所有术后时间点均显著改善,5年时平均0.12 logMAR。
  • 6个月时SIA为2.50±1.04,5年时2.53±1.39(p=0.95),无进一步显著变化。

核心结论

  • 无缝合SALK为准分子激光治疗后复发性角膜混浊患者提供了一种有用的治疗选择。
  • 无缝合SALK可至少5年内消除混浊复发并改善BSCVA,尽管可能存在显著SIA。

研究设计与样本

  • 前瞻性干预研究,在意大利Forlì三级转诊中心开展,连续纳入10只眼。
  • 研究对象为光屈光性角膜切削术后角膜混浊、经光治疗性角膜切削术(联合或不联合丝裂霉素C)后复发的眼,接受无缝合SALK,供体和受体均使用微型角膜刀。

主要发现

  • 无术中并发症,术后任何眼均无混浊复发。
  • BSCVA在所有术后时间点均显著改善;平均术前视力从0.46 logMAR(SD=0.12)改善至5年时0.12(SD=0.12,p=0.0001)。
  • 6个月时SIA为2.50±1.04,5年时2.53±1.39(p=0.95),无进一步显著变化。
  • 平均球镜等效值无显著变化,5年时术前与术后散光向量值无显著差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND/AIMS: To evaluate the 5-year outcomes of sutureless superficial anterior lamellar keratoplasty (SALK) in the treatment of surface ablation-related corneal haze recurring after phototherapeutic keratectomy (PTK). METHODS: Prospective interventional study at a tertiary referral centre in Forli, Italy. Ten consecutive eyes with corneal haze following photorefractive keratectomy, recurring after treatment with PTK with or without mitomycin C, undergoing sutureless SALK. Sutureless SALK was performed using a microkeratome in donor and recipient. MAIN OUTCOME MEASURES: best spectacle-corrected visual acuity (BSCVA), surgically induced astigmatism (SIA), rate of recurrence and complications. RESULTS: There were no intraoperative complications and there was no recurrence of haze in any eye postoperatively. BSCVA showed significant improvement at all postoperative time points. Mean preoperative visual acuity improved from 0.46 logMAR units (SD=0.12) to 0.12 (SD=0.12, p=0.0001) at 5 years. At 6 months, SIA was 2.50±1.04 with no further significant change at 5 years (2.53±1.39, p=0.95). There was no significant change in mean spherical equivalent and no significant difference between preoperative and postoperative astigmatism vector values at 5 years. CONCLUSIONS: Sutureless SALK provides a useful treatment option in patients with recurrent haze after excimer laser treatment. It can eliminate haze recurrence for at least a period of 5 years and can improve BSCVA, although there may be significant SIA.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Myerscough J, Bovone C, Thomas PBM, et al. Sutureless superficial anterior lamellar keratoplasty for recurrent corneal haze after repeat excimer laser surface ablation. Br J Ophthalmol. 2019. PMID: 31278147. doi:10.1136/bjophthalmol-2019-314316

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。